# Gilead Sciences net income entity: /record/gilead-sciences.md predicate: net_income page: /record/gilead-sciences/net_income as_of: 2026-11-09 cite: AsOf. "Gilead Sciences quarterly net income: 2,429,000,000 United States dollar", as of 2026-09-30. Claim clm_4B6581046BE2, https://asof.is/claim/clm_4B6581046BE2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/882095/000088209526000039/0000882095-26-000039-index.htm. As of November 9, 2026, the latest net income figure on the AsOf record for Gilead Sciences is $2.43 billion for the quarter ended September 30, 2026, from a primary source (sec.gov). Gilead Sciences's latest full-year net income is $8.51 billion, dated December 31, 2025, from a primary source (sec.gov); the two periods are kept apart, never compared. 19 claims on Gilead Sciences's net income, 1 open and 18 superseded, each dated and sourced; a replaced value is closed with an end date, never deleted. ## Latest net income The newest figure for a shorter period, the quarter ended September 30, 2026: a quarterly_net_income claim, kept apart from the full-year series. - [Gilead Sciences](/record/gilead-sciences.md) | quarterly_net_income | 2,429,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_4B6581046BE2](/claim/clm_4B6581046BE2.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000088209526000039/0000882095-26-000039-index.htm ## Latest full-year net income What the record asserts on 2026-11-09. - [Gilead Sciences](/record/gilead-sciences.md) | net_income | 8,510,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_075AC6F097D8](/claim/clm_075AC6F097D8.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000088209526000006/0000882095-26-000006-index.htm ## Every dated value One claim per line, oldest first. Superseded claims stay visible. - [Gilead Sciences](/record/gilead-sciences.md) | net_income | 1,584,902,000 United States dollar | valid 2007-12-31 to 2008-12-31 | conf 0.95 | superseded | superseded_by [clm_35D02F2808B3](/claim/clm_35D02F2808B3.md) | [clm_9F8A791EDBD9](/claim/clm_9F8A791EDBD9.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000119312510044753/0001193125-10-044753-index.htm - [Gilead Sciences](/record/gilead-sciences.md) | net_income | 1,978,899,000 United States dollar | valid 2008-12-31 to 2009-12-31 | conf 0.95 | superseded | superseded_by [clm_C3B225B42864](/claim/clm_C3B225B42864.md) | [clm_35D02F2808B3](/claim/clm_35D02F2808B3.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000119312510044753/0001193125-10-044753-index.htm - [Gilead Sciences](/record/gilead-sciences.md) | net_income | 2,635,755,000 United States dollar | valid 2009-12-31 to 2010-12-31 | conf 0.95 | superseded | superseded_by [clm_F033D3C42EC9](/claim/clm_F033D3C42EC9.md) | [clm_C3B225B42864](/claim/clm_C3B225B42864.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000119312510044753/0001193125-10-044753-index.htm - [Gilead Sciences](/record/gilead-sciences.md) | net_income | 2,901,257,000 United States dollar | valid 2010-12-31 to 2011-12-31 | conf 0.95 | superseded | superseded_by [clm_696C99F8BC73](/claim/clm_696C99F8BC73.md) | [clm_F033D3C42EC9](/claim/clm_F033D3C42EC9.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000119312511050041/0001193125-11-050041-index.htm - [Gilead Sciences](/record/gilead-sciences.md) | net_income | 2,803,637,000 United States dollar | valid 2011-12-31 to 2012-12-31 | conf 0.95 | superseded | superseded_by [clm_9F2904CE8D05](/claim/clm_9F2904CE8D05.md) | [clm_696C99F8BC73](/claim/clm_696C99F8BC73.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000119312512075335/0001193125-12-075335-index.htm - [Gilead Sciences](/record/gilead-sciences.md) | net_income | 2,591,566,000 United States dollar | valid 2012-12-31 to 2013-12-31 | conf 0.95 | superseded | superseded_by [clm_97D551EB0FC8](/claim/clm_97D551EB0FC8.md) | [clm_9F2904CE8D05](/claim/clm_9F2904CE8D05.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000088209513000015/0000882095-13-000015-index.htm - [Gilead Sciences](/record/gilead-sciences.md) | net_income | 3,074,808,000 United States dollar | valid 2013-12-31 to 2014-12-31 | conf 0.95 | superseded | superseded_by [clm_918922602D80](/claim/clm_918922602D80.md) | [clm_97D551EB0FC8](/claim/clm_97D551EB0FC8.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000088209514000013/0000882095-14-000013-index.htm - [Gilead Sciences](/record/gilead-sciences.md) | net_income | 12,101,000,000 United States dollar | valid 2014-12-31 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_E1EF723628E4](/claim/clm_E1EF723628E4.md) | [clm_918922602D80](/claim/clm_918922602D80.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000088209515000008/0000882095-15-000008-index.htm - [Gilead Sciences](/record/gilead-sciences.md) | net_income | 18,108,000,000 United States dollar | valid 2015-12-31 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_ACDE59759096](/claim/clm_ACDE59759096.md) | [clm_E1EF723628E4](/claim/clm_E1EF723628E4.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000088209516000039/0000882095-16-000039-index.htm - [Gilead Sciences](/record/gilead-sciences.md) | net_income | 13,501,000,000 United States dollar | valid 2016-12-31 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_E7E834C64911](/claim/clm_E7E834C64911.md) | [clm_ACDE59759096](/claim/clm_ACDE59759096.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000088209517000006/0000882095-17-000006-index.htm - [Gilead Sciences](/record/gilead-sciences.md) | net_income | 4,628,000,000 United States dollar | valid 2017-12-31 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_F6D84B82A4B7](/claim/clm_F6D84B82A4B7.md) | [clm_E7E834C64911](/claim/clm_E7E834C64911.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000088209518000008/0000882095-18-000008-index.htm - [Gilead Sciences](/record/gilead-sciences.md) | net_income | 5,455,000,000 United States dollar | valid 2018-12-31 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_E9B23117B9AF](/claim/clm_E9B23117B9AF.md) | [clm_F6D84B82A4B7](/claim/clm_F6D84B82A4B7.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000088209519000006/0000882095-19-000006-index.htm - [Gilead Sciences](/record/gilead-sciences.md) | net_income | 5,386,000,000 United States dollar | valid 2019-12-31 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_BAAD13DDEE58](/claim/clm_BAAD13DDEE58.md) | [clm_E9B23117B9AF](/claim/clm_E9B23117B9AF.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000088209520000006/0000882095-20-000006-index.htm - [Gilead Sciences](/record/gilead-sciences.md) | net_income | 123,000,000 United States dollar | valid 2020-12-31 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_C45AC1BEB9A4](/claim/clm_C45AC1BEB9A4.md) | [clm_BAAD13DDEE58](/claim/clm_BAAD13DDEE58.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000088209521000008/0000882095-21-000008-index.htm - [Gilead Sciences](/record/gilead-sciences.md) | net_income | 6,225,000,000 United States dollar | valid 2021-12-31 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_5E875C84FD17](/claim/clm_5E875C84FD17.md) | [clm_C45AC1BEB9A4](/claim/clm_C45AC1BEB9A4.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000088209522000007/0000882095-22-000007-index.htm - [Gilead Sciences](/record/gilead-sciences.md) | net_income | 4,592,000,000 United States dollar | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_9ED5DC7A3225](/claim/clm_9ED5DC7A3225.md) | [clm_5E875C84FD17](/claim/clm_5E875C84FD17.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000088209523000007/0000882095-23-000007-index.htm - [Gilead Sciences](/record/gilead-sciences.md) | net_income | 5,665,000,000 United States dollar | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_D66A9204BCB4](/claim/clm_D66A9204BCB4.md) | [clm_9ED5DC7A3225](/claim/clm_9ED5DC7A3225.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000088209524000007/0000882095-24-000007-index.htm - [Gilead Sciences](/record/gilead-sciences.md) | net_income | 480,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_075AC6F097D8](/claim/clm_075AC6F097D8.md) | [clm_D66A9204BCB4](/claim/clm_D66A9204BCB4.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000088209525000006/0000882095-25-000006-index.htm - [Gilead Sciences](/record/gilead-sciences.md) | net_income | 8,510,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_075AC6F097D8](/claim/clm_075AC6F097D8.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000088209526000006/0000882095-26-000006-index.htm ## What replaced what - $1.58 billion (2007-12-31 to 2008-12-31, [clm_9F8A791EDBD9](/claim/clm_9F8A791EDBD9.md)) was replaced by $1.98 billion from 2008-12-31 ([clm_35D02F2808B3](/claim/clm_35D02F2808B3.md)) - $1.98 billion (2008-12-31 to 2009-12-31, [clm_35D02F2808B3](/claim/clm_35D02F2808B3.md)) was replaced by $2.64 billion from 2009-12-31 ([clm_C3B225B42864](/claim/clm_C3B225B42864.md)) - $2.64 billion (2009-12-31 to 2010-12-31, [clm_C3B225B42864](/claim/clm_C3B225B42864.md)) was replaced by $2.9 billion from 2010-12-31 ([clm_F033D3C42EC9](/claim/clm_F033D3C42EC9.md)) - $2.9 billion (2010-12-31 to 2011-12-31, [clm_F033D3C42EC9](/claim/clm_F033D3C42EC9.md)) was replaced by $2.8 billion from 2011-12-31 ([clm_696C99F8BC73](/claim/clm_696C99F8BC73.md)) - $2.8 billion (2011-12-31 to 2012-12-31, [clm_696C99F8BC73](/claim/clm_696C99F8BC73.md)) was replaced by $2.59 billion from 2012-12-31 ([clm_9F2904CE8D05](/claim/clm_9F2904CE8D05.md)) - $2.59 billion (2012-12-31 to 2013-12-31, [clm_9F2904CE8D05](/claim/clm_9F2904CE8D05.md)) was replaced by $3.07 billion from 2013-12-31 ([clm_97D551EB0FC8](/claim/clm_97D551EB0FC8.md)) - $3.07 billion (2013-12-31 to 2014-12-31, [clm_97D551EB0FC8](/claim/clm_97D551EB0FC8.md)) was replaced by $12.1 billion from 2014-12-31 ([clm_918922602D80](/claim/clm_918922602D80.md)) - $12.1 billion (2014-12-31 to 2015-12-31, [clm_918922602D80](/claim/clm_918922602D80.md)) was replaced by $18.11 billion from 2015-12-31 ([clm_E1EF723628E4](/claim/clm_E1EF723628E4.md)) - $18.11 billion (2015-12-31 to 2016-12-31, [clm_E1EF723628E4](/claim/clm_E1EF723628E4.md)) was replaced by $13.5 billion from 2016-12-31 ([clm_ACDE59759096](/claim/clm_ACDE59759096.md)) - $13.5 billion (2016-12-31 to 2017-12-31, [clm_ACDE59759096](/claim/clm_ACDE59759096.md)) was replaced by $4.63 billion from 2017-12-31 ([clm_E7E834C64911](/claim/clm_E7E834C64911.md)) - $4.63 billion (2017-12-31 to 2018-12-31, [clm_E7E834C64911](/claim/clm_E7E834C64911.md)) was replaced by $5.46 billion from 2018-12-31 ([clm_F6D84B82A4B7](/claim/clm_F6D84B82A4B7.md)) - $5.46 billion (2018-12-31 to 2019-12-31, [clm_F6D84B82A4B7](/claim/clm_F6D84B82A4B7.md)) was replaced by $5.39 billion from 2019-12-31 ([clm_E9B23117B9AF](/claim/clm_E9B23117B9AF.md)) - $5.39 billion (2019-12-31 to 2020-12-31, [clm_E9B23117B9AF](/claim/clm_E9B23117B9AF.md)) was replaced by $123 million from 2020-12-31 ([clm_BAAD13DDEE58](/claim/clm_BAAD13DDEE58.md)) - $123 million (2020-12-31 to 2021-12-31, [clm_BAAD13DDEE58](/claim/clm_BAAD13DDEE58.md)) was replaced by $6.23 billion from 2021-12-31 ([clm_C45AC1BEB9A4](/claim/clm_C45AC1BEB9A4.md)) - $6.23 billion (2021-12-31 to 2022-12-31, [clm_C45AC1BEB9A4](/claim/clm_C45AC1BEB9A4.md)) was replaced by $4.59 billion from 2022-12-31 ([clm_5E875C84FD17](/claim/clm_5E875C84FD17.md)) - $4.59 billion (2022-12-31 to 2023-12-31, [clm_5E875C84FD17](/claim/clm_5E875C84FD17.md)) was replaced by $5.67 billion from 2023-12-31 ([clm_9ED5DC7A3225](/claim/clm_9ED5DC7A3225.md)) - $5.67 billion (2023-12-31 to 2024-12-31, [clm_9ED5DC7A3225](/claim/clm_9ED5DC7A3225.md)) was replaced by $480 million from 2024-12-31 ([clm_D66A9204BCB4](/claim/clm_D66A9204BCB4.md)) - $480 million (2024-12-31 to 2025-12-31, [clm_D66A9204BCB4](/claim/clm_D66A9204BCB4.md)) was replaced by $8.51 billion from 2025-12-31 ([clm_075AC6F097D8](/claim/clm_075AC6F097D8.md)) ## Questions this record answers ### What is Gilead Sciences's current net income? The latest figure on the record is $2.43 billion for the quarter ended September 30, 2026, from a primary source (sec.gov). The latest full-year figure is $8.51 billion, dated December 31, 2025, from a primary source (sec.gov). The record asserts both as of November 9, 2026. ### What was Gilead Sciences's net income for the quarter ended September 30, 2026? $2.43 billion for the quarter ended September 30, 2026, dated September 30, 2026, from a primary source (sec.gov) (status valid, confidence 0.95). ### When did Gilead Sciences's net income last change? The latest value on the record is $8.51 billion, dated December 31, 2025; before it the record holds $480 million, dated December 31, 2024 and closed on December 31, 2025. ### What was Gilead Sciences's net income before $8.51 billion? $480 million, valid from December 31, 2024 to December 31, 2025 (status superseded), from a primary source (sec.gov). ## Read on - This page: /record/gilead-sciences/net_income (markdown: /record/gilead-sciences/net_income.md) - Entity twin: /record/gilead-sciences.md ยท timeline: /timelines/gilead-sciences.md - Every company's net income: /facts/net_income.md --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.